Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients - PWR 12.02.2022
powernephron
Published on Dec 13, 2022
Dr. Karen Shalansky, Dr. Kevin Kwok, Dr. Hilary Wu present, "Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients."
Category
- Your Subscription
powernephron -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
35:15
Management of Hyperkalemia in Patients With Hemodialysis-Dependent CKD
35 views 1322 days ago -
25:08
HIF Stabilizer Trials in CKD/HD Patients – What Do the Data Really Show?
34 views 1117 days ago -
24:13
Gestational and Chronic Hypertension - CRASH! Medical Review Series
23 views 865 days ago -
47:17
Renin angiotensin system blockade in COVID-19: A tumultuous year in review
26 views 1298 days ago -
52:24
New Insights into the Diagnosis and Treatment of AKI in Patients with ADHF
30 views 1298 days ago -
30:35
Christopher Blosser, MD - Cancer in Patients with Kidney Disease
28 views 1120 days ago